+86-28-82633987
Synonym name:
Catalogue No.: BP0041
Cas No.: 80952-71-2
Formula: C36H62O9
Mol Weight: 638.872
Botanical Source: Panax ginseng
Purity: 95%~99%
Analysis Method: HPLC-DAD or/and HPLC-ELSD
Identification Method: Mass, NMR
Packing: Brown vial or HDPE plastic bottle
Can be supplied from milligrams to grams. Inquire for bulk scale.
For Reference Standard and R&D, Not for Human Use Directly.
Description:
(20R)-Ginsenoside Rh1 exhibits various pharmacological activities including vasorelaxation, antioxidation, anti-inflammation, and anticancer.
References:
Japanese Journal of Pharmacognosy, 1985, 39:123-5.
Pharmacological Study on Panax ginseng C.A. MEYER V. : Effects of Red Ginseng on the Experimental Disseminated Intravascular Coagulation (4). On Ginsenoside-Rg3, Rh1 and Rh2
METHODS AND RESULTS:
20S, 20R ginsenoside Rg3, 20S, 20R ginsenoside Rh1, and ginsenoside Rh2 isolated from red ginseng were investigated for their effect on blood platelet aggregation and thrombin-induced conversion of fibrinogen to fibrin in vitro.
CONCLUSIONS:
20S, 20R ginsenoside Rg3 inhibited collagen- and ADP-induced blood platelet aggregation. 20S ginsenoside Rg3, 20S, 20R ginsenoside Rh1 inhibited the thrombin-induced conversion of fibrinogen to fibrin.
HPLC of 20(R)-Ginsenoside Rh1
Storage conditions：Short-term storage at 2~8℃, long-term storage at -20 ~ -80℃
160.0700
3.5833
3.5833
.0113
.6949
.3096
Low
73.3254
5.5310
No
No
No
No
No
No
0.0
Yes
No
No
No
Shenshuai
Wenjing
Hedandan
